The abstract is read at the publisher; the summary is JClub's.
Neuroimmune mechanisms are implicated in neuropathic pain, but their clinical relevance and therapeutic potential remain uncertain, limiting immune-based treatment translation.
- Why it matters: Current neuropathic pain care is mainly neuron-focused, offering modest benefits and poor tolerability, while neuroimmune contributions are not yet clearly established in humans.
- What they did: This review synthesizes the latest clinical evidence linking immune processes to neuropathic pain and surveys interventions targeting neuroimmune mechanisms, including novel neuroimmunomodulation therapies.
- The result: It highlights key challenges—such as determining whether neuroimmune changes cause neuropathic pain and designing trials to test treatment-effect heterogeneity—along with directions for evaluating new interventions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.